Skip To Main Content
Peter Kotsoana Montso on Muck Rack

Peter Kotsoana Montso

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Peter Kotsoana

Contact Peter Kotsoana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Combating Antibiotic Resistance in a One Health Context: A Plethora of Frontiers

|
By Daniel Jesuwenu Ajose Verified, Peter Kotsoana Montso, Collins Njie Ateba, Shamsaldeen Ibrahim Saeed
| Preprints.org
Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 28 December 2023 / Approved: 29 December 2023 / Online: 29 December 2023 (11:31:53 CET) Ajose, D.J.; Montso, P.K.; Ateba, C.N.; Saeed, S.I. Combating Antibiotic Resistance in a One Health Context: A Plethora of Frontiers. Preprints 2023, 2023122252.
Open in Who Shared Issue with article?

Safety Properties of Escherichia coli O157:H7 Specific Bacteriophages: Recent Advances for Food Safety

|
By Bukola Opeyemi Oluwarinde, Daniel Jesuwenu Ajose Verified, Tesleem Olatunde Abolarinwa, Peter Kotsoana Montso
| MDPI
1. Introduction Escherichia coli (E. coli) is one of the most thoroughly investigated and characterized living organisms and is widely employed as a research model [1]. Despite the fact that these organisms are known to exist as normal flora in the gastrointestinal tract of humans and other warm-blooded animals, some strains are considered to be pathogenic [2]. In general, E. coli strains linked to human illnesses can be divided into two categories, namely intestinal E.
Open in Who Shared Issue with article?
See all 2 licensed articles (3 Total)